Xarelto (Rivaroxaban) Reduces Recurrent Blood Clots and Total Medical Costs in Morbidly Obese Patients - Cath Lab Digest

Xarelto (Rivaroxaban) Reduces Recurrent Blood Clots and Total Medical Costs in Morbidly Obese Patients  Cath Lab Digest

New real-world study of patients with venous thromboembolism (VTE) and morbid obesity shows safety and effectiveness of Xarelto were similar to warfarin, with ...